ID: ALA5175691

Max Phase: Preclinical

Molecular Formula: C32H29F8N9O2

Molecular Weight: 723.63

Associated Items:

Representations

Canonical SMILES:  C[C@@H](N1CCN(c2ccc(-n3cnn(Cc4cc(C(F)(F)F)cc(C(F)(F)F)c4)c3=O)nc2)CC1)[C@](O)(Cn1cncn1)c1ccc(F)cc1F

Standard InChI:  InChI=1S/C32H29F8N9O2/c1-20(30(51,16-47-18-41-17-43-47)26-4-2-24(33)13-27(26)34)45-6-8-46(9-7-45)25-3-5-28(42-14-25)48-19-44-49(29(48)50)15-21-10-22(31(35,36)37)12-23(11-21)32(38,39)40/h2-5,10-14,17-20,51H,6-9,15-16H2,1H3/t20-,30-/m1/s1

Standard InChI Key:  MCZDILFEHUBONL-PRAQEBQASA-N

Associated Targets(non-human)

Candida parapsilosis 8521 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 723.63Molecular Weight (Monoisotopic): 723.2316AlogP: 4.48#Rotatable Bonds: 9
Polar Surface Area: 110.13Molecular Species: NEUTRALHBA: 11HBD: 1
#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.69CX Basic pKa: 7.13CX LogP: 5.57CX LogD: 5.38
Aromatic Rings: 5Heavy Atoms: 51QED Weighted: 0.22Np Likeness Score: -1.48

References

1. Ghobadi E, Saednia S, Emami S..  (2022)  Synthetic approaches and structural diversity of triazolylbutanols derived from voriconazole in the antifungal drug development.,  231  [PMID:35134679] [10.1016/j.ejmech.2022.114161]

Source